These findings suggest that not all patients may benefit from GLP-1 RAs in terms of weight loss, especially those whose obesity and WR are strongly linked to emotional factors, which may reduce sensitivity to physiological satiety signals. The gene discussed is GLP1R; the disease is obesity disorder.